Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies

Clinical trial NCT03590054 · COMPLETED

Trial details

NCT number: NCT03590054
Sponsor: Rahul Aggarwal
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Stage III Cutaneous Melanoma Stage IV Cutaneous Melanoma Locally Advanced Melanoma Locally Advanced Solid Neoplasm Metastatic Head and Neck Squamous Cell Carcinoma Metastatic Malignant Solid Neoplasm Metastatic Melanoma Metastatic Urothelial Carcinoma Non-Small Cell Lung Carcinoma Stage IB Lung Cancer AJCC v7 Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 Stage III Lung Cancer AJCC v8

Start date: 2018-08-20
Primary completion: 2023-11-30
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.